ArticleESMO gastrointestinal oncology2026

Impact of claudin 18.2 expression on the efficacy of trastuzumab deruxtecan in patients with HER2-positive gastric or gastroesophageal junction cancer.

D Okemoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.